References

No references inside the corpus for this window.

Cited by

• 2011Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety207 cited
• 2012Parasomnias: An Updated Review165 cited
• 2006Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double‐blind controlled study in general practice144 cited
• 2009Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study142 cited
• 2010Insomnia risks and costs: health, safety, and quality of life.138 cited
• 2006Therapeutic Options for Sleep‐Maintenance and Sleep‐Onset Insomnia122 cited
• 2008Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time109 cited
• 2005A method for determining the magnitude of change across different cognitive functions in clinical trials: the effects of acute administration of two different doses alprazolam108 cited
• 2011A Novel Therapy for REM Sleep Behavior Disorder (RBD)95 cited
• 2005Psychotropic Medication Use in Canada95 cited
• 2014Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders76 cited
• 2011A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder66 cited